Performance Score (T2D)—A New Perspective in the Assessment of Six-Minute Walking Tests in Pulmonary Rehabilitation

Author:

Wagner BarbaraORCID,Zdravkovic Andrej,Pirchl Michael,Puhan Milo A.,Zwick Ralf Harun,Grote VincentORCID,Crevenna Richard,Fischer Michael J.ORCID

Abstract

Because absolute changes in outcomes are difficult to interpret and the minimal clinically important difference (MCID) is not suitable to address this challenge, a novel method of classifying outcomes by relating changes to baseline values is warranted. We used the “performance score” (T2D), which reflects individual performance, enabling us to consider the functional status at the beginning of rehabilitation without dealing with the problems of mathematical coupling or regression effects, as encountered in ANCOVA. To illustrate the T2D, we retrospectively analyzed changes in the six-minute walking test (6MWT) in COPD patients undergoing outpatient pulmonary rehabilitation and compared the results with absolute differences related to a predetermined MCID. We evaluated a total of 575 COPD patients with a mean age of 61.4 ± 9.2 years. 6MWT improved significantly, with a mean change of 32.3 ± 71.2. A total of 105/311 participants who had reached the MCID were still classified as “below average” by the T2D. Conversely, 76/264 patients who had not reached the MCID were classified as “above average”. This new performance measure accounts for the patient’s current status and for changes over time, potentially representing a simple and user-friendly tool that can be used to quantify a patient’s performance and response to rehabilitation.

Publisher

MDPI AG

Subject

Clinical Biochemistry

Reference36 articles.

1. Global Burden of Chronic Respiratory Diseases;Viegi;J. Aerosol. Med. Pulm. Drug Deliv.,2020

2. Global prevalence of chronic obstructive pulmonary disease: Systematic review and meta-analysis;Varmaghani;East Mediterr. Health J.,2019

3. World Health Organization (WHO) (2022, July 29). The Global Health Observatory. Available online: https://www.who.int/data/gho.

4. Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease: The GOLD science committee report 2019;Singh;Eur. Respir. J.,2019

5. Acute exacerbations of chronic obstructive pulmonary disease: In search of diagnostic biomarkers and treatable traits;Mathioudakis;Thorax,2020

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3